T1	Intervention 211 219	(TGF-Î²)
T2	Intervention 346 347	.
T3	Intervention 348 381	TGF-beta receptor type-2 (TGFBR2)
T4	Intervention 608 628	randomised tamoxifen
T5	Intervention 696 711	examined TGFBR2
T6	Intervention 771 792	target SMAD2 (pSMAD2)
T7	Intervention 801 840	in cancer-associated fibroblasts (CAFs)
T8	Intervention 1753 1764	transfected
T9	Intervention 1787 1791	with
